NorthWest Biotherapeutics Inc (NWBO)

[TZOR]

To be clear I think the PR is very positive overall in the sense that there is validation for ongoing trials from big pharma. Eat it AF

Where I am understanding of the negative is the issue of the equity transfers/compensation. I am not that worried about it for 2 reasons, one the Nasdaq is and will be working with NWBO to remedy the matter. NWBO will work to remedy the matter quickly lest they risk Nasdaq reprimand which is not going to start with delisting and there are due process measures in place for NWBO. As of current there is no reprimand just notification and conveyance to remedy. Two, if that means that the amount of shares issued to Cognate for the services provided will be less than initially awarded, then there are more shares available to NWBO.